Global Spatial Genomics & Transcriptomics Market Size study & Forecast, by Technology (Spatial Transcriptomics, Spatial Genomics) by Product (Instruments, Consumables, Software) by End Use (Translational Research, Academic Customers, Diagnostic Customers,

Global Spatial Genomics & Transcriptomics Market Size study & Forecast, by Technology (Spatial Transcriptomics, Spatial Genomics) by Product (Instruments, Consumables, Software) by End Use (Translational Research, Academic Customers, Diagnostic Customers, Pharmaceutical Manufacturer), and Regional Analysis, 2022-2029

Global Spatial Genomics & Transcriptomics Market is valued at approximately USD 181.98 million in 2021 and is anticipated to grow with a healthy growth rate of more than 11.10% over the forecast period 2022-2029. Genomic research provides a comprehensive view of the full set of genetic instructions provided by DNA, as opposed to transcriptomics, which studies the patterns of gene expression. The research of all genes and the mRNAs that they are coupled with is known as genomics or transcriptomics, respectively. Spatial genomics holds considerable potential for the diagnosis and treatment of disease due to the availability of quantitative gene expression data and the visualization mapping of DNA and RNA into tissue components. The Spatial Genomics & Transcriptomics Market is expanding because of factors such as Studies on tissue-specific gene expression, embryogenesis, in-vitro fertilization, characterization of non-coding RNAs, stem cell and cancer research, among others, rising prevalence of cancer as well as Advent of the fourth generation of sequencing (in situ sequencing).

The rising prevalence of cancer across the globe is fostering market growth. As Spatial Genomics & Transcriptomics is widely used to perform cancer research activities. The rising prevalence of cancer globally is fostering market growth, the International Agency for Research on Cancer (IARC), the source he estimated increase in the worldwide burden of cancer is to 27.5 million new cases by 2040 from 1.9 million new cases in year 2021. Furthermore, along with fresh developments and product releases, the introduction of preventative disease through genomics by several general hospitals and other concerned organizations would contribute to the market's expansion. For instance, a USD 120 million global programme to strengthen equity and enhance outcomes for families affected by genetic illnesses was launched in November 2021 by Illumina and the Genetic Alliance. Moreover, the National Institute of Health declared in March 2022 that it has a dataset of almost 100,000 whole-genome sequencing from widely varied organisms. This demonstrates that government organizations in North America place a significant emphasis on genetics, which will drive the market's expansion over the projection period. However, the gradual adoption of single-cell sequencing and the introduction of novel platforms and technologies for genomics & transcriptomics studies may halt market growth.

The key regions considered for the Global Spatial Genomics & Transcriptomics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the region's increasing disease prevalence and rising clinical research activities in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and rising prevalence of various diseases, an increase in the number of collaborations for medicine development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
Natera Inc.
10x Genomics
Dovetail Genomics LLC
Illumina, Inc.
S2 Genomics, Inc.
NanoString Technologies, Inc.
Seven Bridges Genomics
Horizon Discovery Group plc
CARTANA AB
READCOOR, INC.

Recent Developments in the Market:
 In May 2022, to facilitate spatial biology research using next-generation sequencing, NanoString unveiled a seamless, cloud-based workflow that enhances the spatial data analysis experience for customers using Illumina NextSeq 1000 and NextSeq 2000 sequencing systems as well as the GeoMx Digital Spatial Profiler.
 In January 2022, Illumina Inc. and Nashville Biosciences LLC, a fully owned subsidiary of Vanderbilt University Medical Center (VUMC), made a deal over several years to use Illumina's next-generation sequencing (NGS) platforms to create a premier clinical genomic resource and hasten the development of new drugs.




Global Spatial Genomics & Transcriptomics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology, Product, End Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:
Spatial Transcriptomics
Spatial Genomics

By Product:
Instruments
Consumables
Software

By End Use:
Translational Research
Academic Customers
Diagnostic Customers
Pharmaceutical Manufacturer


By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned
Natera Inc.
10x Genomics
Dovetail Genomics LLC
Illumina, Inc.
S2 Genomics, Inc.
NanoString Technologies, Inc.
Seven Bridges Genomics
Horizon Discovery Group plc
CARTANA AB
READCOOR, INC.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.